Pursuant to the Directive issued by the Bangladesh Securities and
Exchange Commission (No.SEC/SRMIC/2011/ 1240/445) dated April 27,
2016 to follow July-June as income year with effect from July 1, 2016 in
compliance with the provision of the Finance Act 2015, Beximco
Pharmaceuticals Limited announces for the information of the valued
Shareholders of the Company as follows:
